Chinese Sweet Leaf Tea (Rubus suavissimus) Mitigates LPS-Induced Low-Grade Chronic Inflammation and Reduces the Risk of Metabolic Disorders in a C57BL/6J Mouse Model.

Abstract

Chronic exposure to minute doses of endotoxin elicits intestinal inflammation and impairs the gut barrier function, potentially resulting in systemic inflammation with elevated concentrations of biomarkers associated with metabolic syndrome. This study aimed to investigate the preventive effects of the Rubus suavissimus S. Lee leaf extract in a model of low-grade systemic inflammation. The predominant compounds found in the leaf extract are gallic acids, ellagic acid, and rubusoside. Results of the present study showed that R. suavissimus leaf extract supplementation could help preserve intestinal barrier integrity by upregulating the expression of the tight junction proteins [e.g., zonula occluden-1 (ZO-1) and junctional adhesion molecule-1 (JAMA)] and mucin (MUC)-4 and also suppress the release of plasmatic proinflammatory cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-6, and monocyte chemotactic protein (MCP)-1, while restoring the production of anti-inflammatory adiponectin. We subsequently determined that the leaf extract contributes to restoring glucose metabolic homeostasis through maintaining insulin sensitivity. Furthermore, our mechanistic finding demonstrated that the R. suavissimus leaf extract supplementation prevented systemic inflammation-driven impaired insulin sensitivity in white adipose tissues (WATs) by modulating the expression of peroxisome-proliferator-activated receptor-γ (PPAR-γ) and insulin receptor subset-1 (IRS-1). Altogether, our findings suggest that the above supplementation contributes to restoring immune and metabolic homeostasis to enhance the overall health of the host thereby preventing the early onset of metabolic disorders such as obesity and type 2 diabetes.